Archive - May 2022
AstraZeneca’s COVID-19 vaccine receives EMA approval for use as third-dose booster
Positive CHMP opinion issued for PTC Therapeutics’ Upstaza
PTC Therapeutic’s Upstaza has been recommended by both the EMA and CHMP
CHMP recommends Sanofi’s Xenpozyme for rare disease ASMD
[Solutions Spotlight] Stop the stall: The time is now for predictive maintenance in pharma
Tips for selecting a construction partner
EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine
UICC launches global ATOM Coalition to increase access to essential cancer medicines